Drug Search Results
More Filters [+]

hydroxyethylstarch

Alternative Names: hydroxyethylstarch
Latest Update: 2020-01-28
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: N/A

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Austria | Bosnia | Brazil | Bulgaria | Canada | Chile | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Finland | Germany | Greece | Hungary | Iceland | Indonesia | Ireland | Italy | Japan | Latvia | Lebanon | Lithuania | Luxembourg | Malta | Mexico | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | Spain | Sweden | Switzerland | Taiwan | Turkey | Ukraine | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for hydroxyethylstarch

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title